Ashish Mandelia
VP, Controller, Mersana Therapeutics (United States).
Companies
- Mersana Therapeutics (United States)VP, Controller Jan 16, 2020 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Mersana Therapeutics (United States)0 shares2Jan 6, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 6, 2026U 2,300 shares of Mersana Therapeutics (United States)2
- Jan 16, 2025Sold 3,554 shares at $0.58 of Mersana Therapeutics (United States)3
- Jan 15, 2025Exercised options 4,166 shares of Mersana Therapeutics (United States)3
- Jan 15, 2025Sold 1,791 shares at $0.63 of Mersana Therapeutics (United States)4
- Jan 15, 2025Exercised options 4,519 shares of Mersana Therapeutics (United States)3
- Jan 14, 2025Sold 1,007 shares at $0.66 of Mersana Therapeutics (United States)5
- Jan 14, 2025Exercised options 4,783 shares of Mersana Therapeutics (United States)4
- Jan 13, 2025Exercised options 2,646 shares of Mersana Therapeutics (United States)5
- Oct 3, 2024Sold 3,361 shares at $1.96 of Mersana Therapeutics (United States)6
- Oct 2, 2024Sold 4,855 shares at $2.00 of Mersana Therapeutics (United States)6
- Oct 1, 2024Exercised options 30,000 shares of Mersana Therapeutics (United States)6
- Jan 16, 2024Sold 5,025 shares at $2.71 of Mersana Therapeutics (United States)7
- Jan 15, 2024Exercised options 833 shares of Mersana Therapeutics (United States)7
- Jan 15, 2024Exercised options 4,519 shares of Mersana Therapeutics (United States)7
- Jan 14, 2024Exercised options 4,783 shares of Mersana Therapeutics (United States)7
- Jan 13, 2024Exercised options 2,645 shares of Mersana Therapeutics (United States)7
- Jan 17, 2023Sold 3,575 shares at $5.74 of Mersana Therapeutics (United States)8
- Jan 15, 2023Exercised options 833 shares of Mersana Therapeutics (United States)8
- Jan 15, 2023Exercised options 4,519 shares of Mersana Therapeutics (United States)8
- Jan 14, 2023Exercised options 4,784 shares of Mersana Therapeutics (United States)8
- Jan 18, 2022Sold 1,982 shares at $5.92 of Mersana Therapeutics (United States)9
- Jan 14, 2022Exercised options 5,353 shares of Mersana Therapeutics (United States)9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jan 17, 2025
- 4SEC EDGARForm 4 filed Jan 16, 2025
- 5SEC EDGARForm 4 filed Jan 15, 2025
- 6SEC EDGARForm 4 filed Oct 7, 2024
- 7SEC EDGARForm 4 filed Jan 17, 2024
- 8SEC EDGARForm 4 filed Jan 18, 2023
- 9SEC EDGARForm 4 filed Jan 19, 2022